Intra-Cellular Therapies Inc (ITCI)
64.96
-0.60
(-0.92%)
USD |
NASDAQ |
May 10, 16:00
64.96
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Price: 64.96 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 10, 2024 | 65.75 | 66.71 | 64.92 | 64.96 | 723764.0 |
| May 09, 2024 | 66.97 | 67.23 | 65.45 | 65.56 | 767145.0 |
| May 08, 2024 | 71.12 | 71.22 | 66.95 | 67.00 | 994208.0 |
| May 07, 2024 | 69.72 | 71.64 | 68.61 | 71.21 | 1.128M |
| May 06, 2024 | 68.88 | 71.02 | 68.26 | 71.01 | 750134.0 |
| May 03, 2024 | 71.07 | 71.35 | 68.48 | 68.80 | 909098.0 |
| May 02, 2024 | 73.77 | 73.77 | 69.98 | 70.34 | 1.234M |
| May 01, 2024 | 71.61 | 73.68 | 71.61 | 72.73 | 714823.0 |
| Apr 30, 2024 | 72.45 | 72.82 | 71.38 | 71.81 | 840680.0 |
| Apr 29, 2024 | 73.58 | 73.82 | 71.97 | 72.30 | 552276.0 |
| Apr 26, 2024 | 72.27 | 73.52 | 71.66 | 73.26 | 594803.0 |
| Apr 25, 2024 | 72.46 | 72.78 | 71.35 | 72.13 | 658777.0 |
| Apr 24, 2024 | 73.74 | 74.12 | 72.41 | 73.12 | 736512.0 |
| Apr 23, 2024 | 75.06 | 76.89 | 73.69 | 74.01 | 826601.0 |
| Apr 22, 2024 | 73.68 | 75.14 | 72.02 | 74.54 | 1.928M |
| Apr 19, 2024 | 72.31 | 74.56 | 70.93 | 72.37 | 2.189M |
| Apr 18, 2024 | 74.40 | 75.08 | 71.20 | 72.00 | 4.711M |
| Apr 17, 2024 | 79.00 | 83.25 | 76.50 | 76.69 | 2.862M |
| Apr 16, 2024 | 75.29 | 84.89 | 75.00 | 79.84 | 7.381M |
| Apr 15, 2024 | 65.71 | 66.05 | 64.16 | 64.76 | 503322.0 |
| Apr 12, 2024 | 68.04 | 68.67 | 64.84 | 65.88 | 586929.0 |
| Apr 11, 2024 | 67.89 | 68.68 | 66.53 | 67.97 | 431105.0 |
| Apr 10, 2024 | 67.12 | 68.12 | 66.53 | 67.28 | 541589.0 |
| Apr 09, 2024 | 68.07 | 69.02 | 67.90 | 68.62 | 493243.0 |
| Apr 08, 2024 | 68.74 | 68.90 | 67.32 | 67.70 | 376861.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.26
Minimum
Oct 01 2019
79.84
Maximum
Apr 16 2024
40.21
Average
41.68
Median
Jun 11 2021
Price Benchmarks
| Johnson & Johnson | 149.91 |
| Insmed Inc | 25.97 |
| Madrigal Pharmaceuticals Inc | 205.25 |
| Vertex Pharmaceuticals Inc | 422.78 |
| Fate Therapeutics Inc | 4.08 |
Price Related Metrics
| PS Ratio | 12.21 |
| Price to Book Value | 11.44 |
| Earnings Yield | -1.79% |
| Market Cap | 6.858B |